Gandra, SumanthBraykov, NikolayLaxminarayan, Ramanan2022-08-232022-08-232013-04-012013-07-02<p>Gandra S, Braykov N, Laxminarayan R. East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States. Infect Control Hosp Epidemiol. 2013 Apr;34(4):443-5. doi: 10.1086/669872. <a href="http://www.jstor.org/stable/10.1086/669872">Link to article on publisher's site</a></p>0899-823X (Linking)10.1086/66987223466924https://hdl.handle.net/20.500.14038/28887We read the article of Hayakawa et al with great interest. The report describes the growing prevalence of vancomycin-resistant Enterococcus faecalis in Michigan, a state that also has the most reports of vancomycin-resistant Staphylococcus aureus. Similar findings were reported in the tigecycline evaluation and surveillance trial (TEST). During the 2004–2009 period, 4.6% of 3,753 E. faecalis isolates were vancomycin resistant, with the highest rates of 7.6% in the East North Central region of United States. Here we report rates and trends of vancomycin-resistant E. faecalis in the East North Central region compared with national rates from 1999 to 2010.en-USPublisher PDF posted as allowed by the publisher's author rights policy at http://www.press.uchicago.edu/journals/jrnl_rights.html#faq4.Enterococcus faecalisVancomycin ResistanceAmino Acids, Peptides, and ProteinsBacteriaBacterial Infections and MycosesCarbohydratesEpidemiologyImmunology and Infectious DiseaseMicrobiologyPharmaceutical PreparationsTherapeuticsLetter to the Editorhttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1111&amp;context=faculty_pubs&amp;unstamped=1https://escholarship.umassmed.edu/faculty_pubs/1124276328faculty_pubs/112